JmjC-domain-containing proteins and histone demethylation

Nature Reviews Genetics

Volumn 7, Issue 9, 2006, Pages 715-727

  Klose, Robert J ^a   Kallin, Eric M ^a   Zhang, Yi ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DNA; F BOX PROTEIN; HISTONE; HISTONE DEMETHYLASE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HISTONE METHYLTRANSFERASE; LYSINE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CAENORHABDITIS ELEGANS; CELL FATE; CHROMATIN STRUCTURE; DEMETHYLATION; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; EPIGENETICS; EVOLUTION; GENE EXPRESSION REGULATION; HOMEOBOX; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN METHYLATION; TRANSCRIPTION REGULATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC;

EID: 33747455678     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg1945     Document Type: Article

References (101)

1. Martin, C. & Zhang, Y. The diverse functions of histone lysine methylation. Nature Rev. Mol. Cell Biol. 6, 838-849 (2005).
2. Vakoc, C. R., Mandat, S. A., Olenchock, B. A. & Blobel, G. A. Histone H3 lysine 9 methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Mol. Cell 19, 381-391 (2005).
3. Carrozza, M. J. et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123, 581-592 (2005).
4. Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromodomain. Nature 410, 120-124 (2001).
5. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120 (2001).
6. Wysocka, J. et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442, 91-95 (2006).
7. Wang, Y. et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279-283 (2004).
8. Cuthbert, G. L. et al. Histone deimination antagonizes arginine methylation. Cell 118, 545-553 (2004). References 7 and 8 identify PADI4 as the first enzyme capable of antagonizing histone arginine methylation.
9. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004). Identifies the first true histone demethylase enzyme, LSD1, which utilizes flavin as a cofactor to carry out an oxidative demethylation reaction.
10. Metzger, E. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439 (2005).
11. Lee, M. G., Wynder, C., Cooch, N. & Shiekhattar, R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432-435 (2005).
12. Shi, Y. J. et al. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19, 857-864 (2005).
13. Tsukada, Y. et al. Histone demethylation by a family of JmjC-domain-containing proteins. Nature 439, 811-816 (2006). The authors used a novel in vitro histone demethylase assay to biochemically purify and characterize the first JmjC-domain-containing histone demethylase enzyme.
14. Yamane, K. et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125, 483-495 (2006). The authors biochemically purified a novel JmjC-domain-containing histone H3K9 demethylase and demonstrated its role in androgen receptor-mediated gene activation.
15. Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481 (2006).
16. Klose, R. et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and 36. Nature 442, 312-316 (2006).
17. Cloos, P. A. et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442, 307-311 (2006).
18. Fodor, B. D. et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20, 1557-1562 (2006). References 15 to 18 demonstrate that the JHDM3/JMJD2 histone demethylase enzymes are capable of removing the trimethyl modification state.
19. Clissold, P. M. & Ponting, C. P. JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2β. Trends Biochem. Sci. 26, 7-9 (2001). The authors identify bioinformatic and structural similarities between metalloenzymes and JmjC-domain-containing proteins.
20. Takeuchi, T. et al. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev. 9, 1211-1222 (1995). The authors cloned the Jumonji protein in a gene-trap screen for factors involved in neural tube formation. The JmjC domain was later named on the basis of its presence in the Jumonji protein.
21. Balciunas, D. & Ronne, H. Evidence of domain swapping within the Jumonji family of transcription factors. Trends Biochem. Sci. 25, 274-276 (2000).
22. Dunwell, J. M. & Gane, P. J. Microbial relatives of seed storage proteins: conservation of motifs in a functionally diverse superfamily of enzymes. J. Mol. Evol. 46, 147-154 (1998).
23. Lando, D. et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471 (2002). The authors identify the JmjC-domain-containing protein FIH as an asparaginyl hydroxylase enzyme and for the first time demonstrate enzymatic activity for a mammalian JmjC-domain protein.
24. Trewick, S. C., McLaughlin, P. J. & Allshire, R. C. Methylation: lost in hydroxylation? EMBO Rep. 6, 315-320 (2005). The authors propose that JmjC-domain-containing proteins might function as histone demethylases based on the function of the fission yeast JmjC-domain protein Epe1 in regulating silent chromatin structure.
25. Dann, C. E., Bruick, R. K. & Deisenhofer, J. Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Proc. Natl Acad. Sci. USA 99, 15351-15356 (2002).
26. Elkins, J. M. et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF1α. J. Biol. Chem. 278, 1802-1806 (2003).
27. Lee, C., Kim, S. J., Jeong, D. G., Lee, S. M. & Ryu, S. E. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J. Biol. Chem. 278, 7558-7563 (2003).
28. Chen, Z. et al. Structural insights into histone demethylation by JMJD2 family members. Cell 125, 691-702 (2006). A report of the first crystal structure of the enzymatic domain of an active JmjC-domain-containing histone demethylase, JHDM3A/JMJD2A.
29. Clifton, I. J. et al. Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins. J. Inorg. Biochem. 100, 644-669 (2006).
30. Chenna, R. et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31, 3497-3500 (2003).
31. Huelsenbeck, J. P. & Ronquist, F. MrBayes: Bayesian inference of phylogenetic trees. Bioinformatics 17, 754-755 (2001).
32. Ronquist, F. & Huelsenbeck, J. P. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572-1574 (2003).
33. Pothof, J. et al. Identification of genes that protect the Caenorhabditis elegans genome against mutations by genome-wide RNAi. Genes Dev. 17, 443-448 (2003).
34. Ayoub, N. et al. A novel JmjC domain protein modulates heterochromatization in fission yeast. Mol. Cell. Biol. 23, 4356-4370 (2003). The authors show that Epe1 has important roles in modulating heterochromatin formation and provide a basis for speculation that the JmjC domain might have histone demethylase activity.
35. Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274 (1996).
36. Ayton, P. M., Chen, E. H. & Cleary, M. L. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol. Cell. Biol. 24, 10470-10478 (2004).
37. Jorgensen, H. F., Ben-Porath, I. & Bird, A. P. MBD1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol. Cell. Biol. 24, 3387-3395 (2004).
38. Lee, J. H. & Skalnik, D. G. CpG-binding protein (CXXC finger protein 1) is a component of the mammalian SET1 histone H3-Lys4 methyltransferase complex, the analogue of the yeast SET1/COMPASS complex. J. Biol. Chem. 280, 41725-41731 (2005).
39. Zofall, M. & Grewal, S. I. Swi6/HP1 recruits a JmjC-domain protein to facilitate transcription of heterochromatic repeats. Mol. Cell 22, 681-692 (2006). The authors demonstrate that Epe1 functions in heterochromatin to promote Pol II accessibility by counteracting repressive chromatin.
40. Hasenpusch-Theil, K. et al. PHF2, a novel PHD finger gene located on human chromosome 9q22. Mamm. Genome 10, 294-298 (1999).
41. Laumonnier, F. et al. Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J. Med. Genet. 42, 780-786 (2005).
42. Siderius, L. E. et al. X linked mental retardation associated with cleft lip/palate maps to Xp11.3-q21.3. Am. J. Med. Genet. 85, 216-220 (1999).
43. Fernandez, A. G. et al. New genes with roles in the Caenorhabditis elegans embryo revealed using RNAi of ovary-enriched ORFeome clones. Genome Res. 15, 250-259 (2005).
44. Chelly, J. & Mandel, J. L. Monogenic causes of X linked mental retardation. Nature Rev. Genet. 2, 669-680 (2001).
45. Defeo-Jones, D. et al. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352, 251-254 (1991).
46. Kratzke, R. A. et al. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9, 1321-1326 (1994).
47. Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A. & Kaelin, W. G. Jr. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18, 623-635 (2005).
48. Chan, S. W. & Hong, W. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J. Biol. Chem. 276, 28402-28412 (2001).
49. Lu, P. J. et al. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically upregulated in breast cancer. J. Biol. Chem. 274, 15633-15645 (1999).
50. Madsen, B. et al. PLU-1, a transcriptional repressor and putative testis-cancer antigen, has a specific expression and localisation pattern during meiosis. Chromosoma 112, 124-132 (2003).
51. Madsen, B. et al. Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically upregulated in breast cancer. Mech. Dev. 119, S239-S246 (2002).
52. Tan, K. et al. Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9. J. Biol. Chem. 278, 20507-20513 (2003).
53. Wang, W. et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269, 1588-1590 (1995).
54. Scott, D. M. et al. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 376, 695-698 (1995).
55. Gildea, J. J., Lopez, R. & Shearn, A. A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2. Genetics 156, 645-663 (2000).
56. Jung, J., Mysliwiec, M. R. & Lee, Y. Roles of JUMONJI in mouse embryonic development. Dev. Dyn. 232, 21-32 (2005).
57. Takeuchi, T., Kojima, M., Nakajima, K. & Kondo, S. Jumonji gene is essential for the neurulation and cardiac development of mouse embryos with a C3H/He background. Mech. Dev. 86, 29-38 (1999).
58. Jung, J., Kim, T. G., Lyons, G. E., Kim, H. R. & Lee, Y. Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein. J. Biol. Chem. 280, 30916-30923 (2005).
59. Kim, T. G., Chen, J., Sadoshima, J. & Lee, Y. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol. Cell. Biol. 24, 10151-10160 (2004).
60. Kim, T. G., Jung, J., Mysliwiec, M. R., Kang, S. & Lee, Y. Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity. Biochem. Biophys. Res. Commun. 329, 544-553 (2005).
61. Ringrose, L. & Paro, R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413-443 (2004).
62. Katoh, M. & Katoh, M. Identification and characterization of JMJD2 family genes in silico. Int. J. Oncol. 24, 1623-1628 (2004).
63. Yang, Z. Q. et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 60, 4735-4739 (2000).
64. Zhang, D., Yoon, H. G. & Wong, J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25, 6404-6414 (2005).
65. Gray, S. G. et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J. Biol. Chem. 280, 28507-28518 (2005).
66. Kim, J. et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7, 397-403 (2006).
67. Huang, Y., Fang, J., Bedford, M. T., Zhang, Y. & Xu, R. M. Recognition of hstone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 312, 748-751 (2006).
68. Bannister, A. J. et al. Spatial distribution of di- and trimethyl lysine 36 of histone H3 at active genes. J. Biol. Chem. 280, 17732-17736 (2005).
69. Jang, Y. K., Wang, L. & Sancar, G. B. RPH1 and GIS1 are damage-responsive repressors of PHR1. Mol. Cell. Biol. 19, 7630-7638 (1999).
70. Greenfield, A. et al. An H-YDb epitope is encoded by a novel mouse Y chromosome gene. Nature Genet. 14, 474-478 (1996).
71. Greenfield, A. et al. The UTX gene escapes X inactivation in mice and humans. Hum. Mol. Genet. 7, 737-742 (1998).
72. Hu, Z. et al. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene 20, 6946-6954 (2001).
73. Cachon-Gonzalez, M. B. et al. Structure and expression of the hairless gene of mice. Proc. Natl Acad. Sci. USA 91, 7717-7721 (1994).
74. Ahmad, W. et al. Alopecia universalis associated with a mutation in the human hairless gene. Science 279, 720-724 (1998).
75. Potter, G. B. et al. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev. 15, 2687-2701 (2001).
76. Hoog, C., Schalling, M., Grunder-Brundell, E. & Daneholt, B. Analysis of a murine male germ cell-specific transcript that encodes a putative zinc finger protein. Mol. Reprod. Dev. 30, 173-181 (1991).
77. Lee, J. W., Choi, H. S., Gyuris, J., Brent, R. & Moore, D. D. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9, 243-254 (1995).
78. Metzen, E. et al. Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326 (2003).
79. Tsuneoka, M., Koda, Y., Soejima, M., Teye, K. & Kimura, H. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem. 277, 35450-35459 (2002).
80. Zhang, Y. et al. The human mineral dust-induced gene, MDIG, is a cell growth regulating gene associated with lung cancer. Oncogene 24, 4873-4882 (2005).
81. Eilbracht, J., Kneissel, S., Hofmann, A. & Schmidt-Zachmann, M. S. Protein NO52 - a constitutive nucleolar component sharing high sequence homologies to protein NO66. Eur. J. Cell Biol. 84, 279-294 (2005).
82. Eilbracht, J. et al. NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin. Mol. Biol. Cell 15, 1816-1832 (2004).
83. Pickard, R. T., Strifler, B. A., Kramer, R. M. & Sharp, J. D. Molecular cloning of two new human paralogs of 85 kDa cytosolic phospholipase A2. J. Biol. Chem. 274, 8823-8831 (1999).
84. Hirabayashi, T., Murayama, T. & Shimizu, T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol. Pharm. Bull. 27, 1168-1173 (2004).
85. Liu, C., Gilmont, R. R., Benndorf, R. & Welsh, M. J. Identification and characterization of a novel protein from Sertoli cells, PASS1, that associates with mammalian small stress protein hsp27. J. Biol. Chem. 275, 18724-18731 (2000).
86. Bodmer, D., Schepens, M., Eleveld, M. J., Schoenmakers, E. F. & Geurts van Kessel, A. Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q21). Genes Chromosomes Cancer 38, 107-116 (2003).
87. Fadok, V. A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90 (2000).
88. Kunisaki, Y. et al. Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood 103, 3362-3364 (2004).
89. Bose, J. et al. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J. Biol. 3, 15 (2004).
90. Cui, P., Qin, B., Liu, N., Pan, G. & Pei, D. Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals. Exp. Cell Res. 293, 154-163 (2004).
91. Cikala, M. et al. The phosphatidylserine receptor from Hydra is a nuclear protein with potential Fe(II) dependent oxygenase activity. BMC Cell Biol. 5, 26 (2004).
92. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
93. Schotta, G. et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18, 1251-1262 (2004).
94. Sun, X. J. et al. Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J. Biol. Chem. 280, 35261-35271 (2005).
95. O'Carroll, D. et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell. Biol. 21, 4330-4336 (2001).
96. Boyer, L. A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353 (2006).
97. Letunic, I. et al. SMART 5: domains in the context of genomes and networks. Nucleic Acids Res. 34, D257-D260 (2006).
98. Schultz, J., Milpetz, F., Bork, P. & Ponting, C. P. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl Acad. Sci. USA 95, 5857-5864 (1998).
99. Bateman, A. et al. The Pfam protein families database. Nucleic Acids Res. 32, D138-D141 (2004).
100. Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881-10890 (1988).
101. Kumar, S., Tamura, K. & Nei, M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 5, 150-163 (2004).